SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001408408-20-000052
Filing Date
2020-11-13
Accepted
2020-11-13 16:14:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A ecl_mrkr13da11132020.htm SC 13D/A 45066
2 EX-1 ecl_mrkr13daex1.htm EX-1 6725
  Complete submission text file 0001408408-20-000052.txt   53582
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2250 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2250 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-58217 | Film No.: 201311648
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006
Business Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006 345-640-3300
Eastern Capital LTD (Filed by) CIK: 0001408408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A